Galectin-1: A Potential Biomarker Differentiating between Early Rheumatoid Arthritis and Spondyloarthritis

Galectin-1: A Potential Biomarker Differentiating between Early Rheumatoid Arthritis and Spondyloarthritis

Galectin-1 (Gal1) plays a regulatory role in the immune system. We have recently validated that Gal1 serum (sGal1) levels are increased in rheumatoid arthritis (RA) patients compared to healthy donors (HDs); however, there is no information on Gal1 in spondyloarthritis (SpA). <b>Objective:<...

Full description

Bibliographic Details
Main Authors: Ana Triguero-Martínez, Emilia Roy-Vallejo, Eva Gloria Tomero, Nuria Montes, Hortensia de la Fuente, Ana María Ortiz, Santos Castañeda, Amalia Lamana, Isidoro González-Álvaro
Format: Article
Language:English
Published: MDPI AG 2022-10-01
Series:Journal of Clinical Medicine
Subjects:
spondyloarthritis
Galectin-1
biomarker
rheumatoid arthritis
early arthritis
Online Access:https://www.mdpi.com/2077-0383/11/21/6313

Internet

https://www.mdpi.com/2077-0383/11/21/6313

Similar Items